E
Endpoint Health
Delivering new precision therapies to patients
About Endpoint Health
Endpoint Health is a pioneering company in the field of precision medicine, focusing on critical illnesses such as sepsis and acute respiratory distress syndrome (ARDS). The company operates in the healthcare sector, specifically targeting patients with severe and life-threatening conditions. Endpoint Health's business model revolves around creating a precision medicine ecosystem that aims to understand patient biology better, how it impacts treatment responses, and to develop new targeted therapies. The company serves hospitals, healthcare providers, and clinical researchers who are in need of advanced, personalized treatment options for their patients. Endpoint Health generates revenue through the development and validation of these targeted therapies, which are then sold to healthcare institutions and providers. The company is committed to ensuring that every critical therapy needed for each patient is available and personalized, thereby improving patient outcomes and reducing hospital deaths.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Palo Alto, United States
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 60.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Precision Medicine, Biotech and Pharma, Hard Tech, YC W19, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jun 2022 | $26M | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Jun 2022 | $26M | $104M | Wireframe Ventures · Alix Ventures · Boom Capital · AME Cloud Ventures | ↗ |
Growth signals
Endpoint Health's team declined 30% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A11 investors entered at this stage
Mayfield
GRIDS Capital
Wireframe Ventures
Alix Ventures- BCBoom Capital
AME Cloud Ventures
Global Health Investment Corporation
Humboldt Fund
The Venture Collective
Yaya Capital- HVHCX Ventures
Other known investors7 additional known investors
Ali Tamaseb
Celestine Schnugg
Chas Pulido
DRIVe - Division of Research, Innovation, and Ventures
Harsh Patel
Knockout Capital
Matthew De Silva
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Endpoint Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Endpoint Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.